One of the biggest challenges in treating ovarian cancer is the fact that most women are not diagnosed until the cancer has already advanced and five-year survival is around 30%. By contrast, early-stage disease is highly treatable, with a survival rate of 90%.

An unusual treatment with a very long name is helping cancer patients who are experiencing xerostomia, one of the side effects of radiation to the head and neck. This dry mouth condition can damage salivary glands, causing chronic oral dryness and slowed salivation.